Codes / ICD10CM / Z19

Z19 Hormone sensitivity malignancy status

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Hormone Sensitivity Malignancy Status

Summary

Hormone sensitivity malignancy status indicates that a cancerous tumor is responsive to hormone-based therapies, which are commonly used to manage cancers such as breast, prostate, or endometrial cancer. This status suggests the cancer relies on hormonal pathways for growth and may respond to treatments targeting these pathways.

Causes

The underlying cause is the presence of hormone receptors on cancer cells, which drive tumor growth in response to hormones. This biological characteristic determines the tumor's sensitivity to hormone-modulating therapies.

Risk Factors

  • Tumor type (e.g., hormone receptor-positive breast or prostate cancer).
  • Genetic factors influencing hormone receptor expression.
  • Age and gender, as certain cancers are more prevalent in specific demographics.

Symptoms

Symptoms are typically related to the primary cancer and may include unexplained weight changes, fatigue, pain, or visible lumps, depending on the tumor's location and progression.

Diagnosis

Diagnosis involves assessing hormone receptor status through biopsy or tissue analysis, often combined with imaging studies to evaluate tumor characteristics and response to prior therapies.

Treatment Options

  • Hormone therapy (e.g., anti-estrogen or anti-androgen medications) to inhibit tumor growth.
  • Surgery or radiation to remove or reduce the tumor, often followed by hormone-based adjuvant therapy.
  • Combination therapies for advanced or resistant cases.

Prognosis and Follow-Up

Prognosis varies by cancer type and stage but is generally more favorable when tumors are hormone-sensitive. Regular follow-up includes monitoring for recurrence, imaging, and hormone receptor testing to guide ongoing treatment.

Complications

  • Hormone therapy side effects (e.g., hot flashes, bone density loss).
  • Tumor progression or resistance to hormone treatments over time.
  • Metastasis to other organs if not effectively managed.

Lifestyle & Prevention

  • Adherence to prescribed hormone therapies and follow-up schedules.
  • Healthy lifestyle choices (e.g., balanced diet, regular exercise) to support overall health.
  • Avoidance of known carcinogens relevant to the specific cancer type.

When to Seek Professional Help

Seek care if new or worsening symptoms (e.g., pain, swelling, unexplained weight loss) occur, or if side effects from hormone therapy become severe or unmanageable.

Tips for Medical Coders

Document the specific cancer type, hormone receptor status, and treatment response to accurately reflect the patient's condition. Ensure the code aligns with clinical documentation of hormone sensitivity and any associated therapies.

Book a walkthrough

Z19 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.